Doctors in the evidence-based medicine world have been researching them for decades, and are optimistic about their ability to act as what are known as signaling molecules, encouraging the body to do things such as regulate blood sugar to help patients with diabetes
Predictors and variation in steroid injection use for carpal tunnel syndrome from a multicenter quality collaborative
The peptide is not FDA-approved for any indication, and carriers do not reimburse off-label peptide therapy regardless of the clinical justification
References: Ozempic list price explanation, Novo Nordisk (2024) Patient Assistance Program (PAP), Novo Nordisk (2024) Wegovy list price explanation, Novo Nordisk (2024) Rybelsus list price explanation, Novo Nordisk (2024) Semaglutide market report, Grand View Research (2024) FDA clarifies policies as GLP-1 supply stabilizes, FDA (2024) Compounded semaglutide: how to better ensure its safety, Medscape (2024) Illicit compounding position, Novo Nordisk (2025)
Neuropeptides 22, 175183